TrialEndocrine2015

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products.

Jhih-Syuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.